Published in Vaccine Weekly, February 9th, 2000
This patent covers dry powder formulations of DNA either as a lipid (cationic) complex or in a viral vector using hydrophilic (water soluble) excipients. Vectors are a means by which DNA is delivered to the target cell. These excipients provide stability to the formulation and enable rapid dissolution, which may be important for enabling the gene to cross membranes and into cells. The...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly